Cargando…
Non-alcoholic Fatty Liver Disease and Liver Fibrosis during Aging
Non-alcoholic fatty liver disease (NAFLD) and its progressive form non-alcoholic steatohepatitis (NASH) have emerged as the leading causes of chronic liver disease-related mortality. The prevalence of NAFLD/NASH is expected to increase given the epidemics of obesity and type 2 diabetes mellitus. Old...
Autores principales: | Li, Yuan, Adeniji, Nia T., Fan, Weiguo, Kunimoto, Koshi, Török, Natalie J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JKL International LLC
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286912/ https://www.ncbi.nlm.nih.gov/pubmed/35855331 http://dx.doi.org/10.14336/AD.2022.0318 |
Ejemplares similares
-
Progressive Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
por: Ramai, Daryl, et al.
Publicado: (2021) -
Non-invasive biomarkers of liver fibrosis in non-alcoholic fatty liver disease
por: Basheer, Maamon, et al.
Publicado: (2023) -
Clinical assessment and management of liver fibrosis in non-alcoholic fatty liver disease
por: Campos-Murguía, Alejandro, et al.
Publicado: (2020) -
Elastography Techniques for the Assessment of Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
por: Honda, Yasushi, et al.
Publicado: (2020) -
Metabolic inflammation as an instigator of fibrosis during non-alcoholic fatty liver disease
por: Katsarou, Angeliki, et al.
Publicado: (2020)